Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKier Regulatory News (KIE)

Share Price Information for Kier (KIE)

Share Price is delayed by 15 minutes
Get Live Data
210.60    3.00 (1.45%)
Bid:
209.80
Ask:
210.20
Spread: 0.40 (0.191%)
Market Cap: £916.68m
KIE Live PriceLast checked at - London Stock Exchange

Intraday Kier Share Chart

Trading Update

16 Jan 2020 07:00

RNS Number : 9553Z
Kier Group PLC
16 January 2020
 

16 January 2020

 

Kier Group plc

 

Trading update

 

Kier Group plc ("the Group") issues an update on trading for the period from 15 November 2019 (the date of its AGM trading update) to 31 December 2019 ("the period") and certain other developments during the period.

 

Trading

Trading for the period was in line with the Board's expectations. The Group continues to be awarded new contracts across the markets in which it operates, including being appointed to all 20 lots of the four-year £8bn Procure Partnerships Framework in November 2019.

 

Net debt

The Group continued to manage its net debt closely during the period. The Group's average month-end net debt for the six-month period to 31 December 2019 was in line with the Board's expectations.

 

FY2020 interim results

Under its new leadership team, the Group will bring forward the date on which it announces its results for the six-month period ended 31 December 2019 from 19 March 2020 to 5 March 2020.

 

Strategic actions

The Group continues to make good progress with respect to its office closures, the outsourcing of certain functions and the reduction in headcount. The Group expects to deliver a headcount reduction of c.1,200 by 30 June 2020 and annual cost savings of at least £60m in the financial year ending 30 June 2021 and is reviewing further cost optimisation opportunities.

The Group continues to progress the disposal of Kier Living, its housebuilding business, and to evaluate the options for its Property business.

 

Chairman

As announced on 16 December 2019, Matthew Lester was appointed as Chairman of the board of directors ("the Board") with effect from 1 January 2020, replacing Phillip Cox who stood down as Chairman and from the Board on that date.

 

Andrew Davies, Chief Executive, commented:

 

"The work to re-shape the Group continues through the careful execution of our strategic priorities and efforts to significantly reduce the Group's cost base. The Group is performing in line with our expectations and we continue to win work from our customers."

 

- ENDS -

 

 

 

For further information, please contact:

 

Kier press office

 

+44 (0)1767 355 096

Richard Mountain / Nick Hasell, FTI Consulting

+44 (0)203 727 1340

 

 

This announcement does not constitute an offer of securities by Kier Group plc (the "Company"). Nothing in this announcement is intended to be, or intended to be construed as, a profit forecast or a guide as to the performance, financial or otherwise, of the Company or any of its subsidiaries (together, the "Group") whether in the current or any future financial year. This announcement may include statements that are, or may be deemed to be, ''forward-looking statements''. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future and may be beyond the Company's or the Group's ability to control or predict. Forward-looking statements are not guarantees of future performance. You are advised to read the section headed ''Principal risks and uncertainties'' in the Company's Annual Report and Accounts for the year ended 30 June 2019 for a further discussion of the factors that could affect the Company's or the Group's future performance and the industry in which it operates. Other than in accordance with its legal or regulatory obligations, the Company does not accept any obligation to update or revise publicly any forward-looking statement, whether as a result of new information, future events or otherwise.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTGPUBCGUPUGBA
Date   Source Headline
30th Jan 20257:00 amRNSTransaction in Own Shares
29th Jan 20257:00 amRNSTransaction in Own Shares
28th Jan 20257:00 amRNSTransaction in Own Shares
27th Jan 20257:00 amRNSTransaction in Own Shares
24th Jan 20257:33 amRNSTransaction in Own Shares
21st Jan 20252:11 pmRNSDirector/PDMR Shareholding
21st Jan 20257:01 amRNSLaunch of £20m share buyback programme
21st Jan 20257:00 amRNSTrading Update
2nd Jan 202511:05 amRNSBlock listing Interim Review
20th Dec 202411:20 amRNSDirector/PDMR Shareholding
13th Dec 20241:11 pmRNSDirector/PDMR Shareholding
10th Dec 20243:34 pmRNSDirector/PDMR Shareholding
6th Dec 202410:37 amRNSHolding(s) in Company
5th Dec 20249:14 amRNSNotification of Change of Director Details
4th Dec 20244:43 pmRNSDirector/PDMR Shareholding
2nd Dec 20242:39 pmRNSTotal Voting Rights
20th Nov 20244:03 pmRNSDirector/PDMR Shareholding
18th Nov 202411:47 amRNSHolding(s) in Company
14th Nov 20242:45 pmRNSResult of AGM
14th Nov 20247:00 amRNSAGM Trading Update
13th Nov 20242:58 pmRNSHolding(s) in Company
8th Nov 202410:36 amRNSDirector/PDMR Shareholding
4th Nov 20245:28 pmRNSHolding(s) in Company
1st Nov 202410:33 amRNSTotal Voting Rights
30th Oct 20243:21 pmRNSDirector/PDMR Shareholding
29th Oct 202411:26 amRNSBlock Listing Application
22nd Oct 202412:47 pmRNSDirector/PDMR Shareholding
16th Oct 20244:23 pmRNSAnnual Financial Report Amendment
14th Oct 20242:53 pmRNSDirector/PDMR Shareholding
4th Oct 202412:00 pmRNSAnnual Financial Report
1st Oct 202412:09 pmRNSTotal Voting Rights
23rd Sep 20242:03 pmRNSHolding(s) in Company
23rd Sep 202410:21 amRNSDirector/PDMR Shareholding
12th Sep 20247:05 amRNSDirectorate Change
12th Sep 20247:00 amRNSFY24 Results
6th Sep 20242:29 pmRNSHolding(s) in Company
2nd Sep 202412:33 pmRNSTotal Voting Rights
22nd Aug 20241:51 pmRNSDirector/PDMR Shareholding
12th Aug 20245:32 pmRNSNotice of Results and Presentations
1st Aug 20249:59 amRNSTotal Voting Rights
18th Jul 20247:00 amRNSFull Year 2024 Trading Update
16th Jul 20243:38 pmRNSHolding(s) in Company
1st Jul 202410:31 amRNSBlock listing Interim Review
1st Jul 202410:28 amRNSTotal Voting Rights
28th Jun 20244:34 pmRNSDirector/PDMR Shareholding
27th Jun 20244:20 pmRNSHolding(s) in Company
20th Jun 202411:53 amRNSDirector/PDMR Shareholding
13th Jun 20243:10 pmRNSDirector/PDMR Shareholding
7th Jun 202410:41 amRNSDirector/PDMR Shareholding
4th Jun 20244:58 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.